Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia

Vanderson Rocha, Annalisa Ruggeri, Stephen Spellman, Tao Wang, Ronald Sobecks, Franco Locatelli, Medhat Askar, Gerard Michel, William Arcese, Anna Paola Iori, Duncan Purtill, Robert Danby, Guillermo F. Sanz, Eliane Gluckman, Mary Eapen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effect of killer cell immunoglobulin-like receptor (KIR)-ligand matching on outcomes after unrelated cord blood (CB) transplantation was studied in 461 patients with acute myeloid leukemia, categorizing KIR ligand for HLA-C groups C1 and C2 and Bw4. Donor-recipient HLA matching considered allele-level matching at HLA-A, -B, -C, and -DRB1. Separate analyses were conducted for 6-7/8 HLA-matched and 3-5/8 HLA-matched transplants because HLA matching confounded KIR-ligand matching (ie, KIR-ligand mismatching was less likely with better HLA matching). All patients received single CB unit and myeloablative conditioning. There were no significant differences in nonrelapse mortality (NRM), relapse, and overall mortality by KIR-ligand match status. However, among recipients of 3-5/8 HLA-matched transplants, NRM (HR, 2.26; P = .008) and overall mortality (HR, 1.78; P = .008) but not relapse were higher with KIR-ligand mismatched (host-versus-graft direction) compared with KIR-ligand matched transplants. These data do not support selecting CB units based on KIR-ligand match status for transplants mismatched at 1 or 2 HLA loci. Although transplants mismatched at 3 or more HLA loci are not recommended, avoiding KIR-ligand mismatching in this setting lowers mortality risks.

Original languageEnglish
Pages (from-to)1284-1289
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume22
Issue number7
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

KIR Receptors
Fetal Blood
Acute Myeloid Leukemia
Transplantation
Ligands
Transplants
Mortality
HLA-C Antigens
Recurrence
HLA-A Antigens
HLA-B Antigens
Alleles
Tissue Donors

Keywords

  • Acute leukemia
  • Cord blood
  • KIR ligand
  • Unrelated transplant

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. / Rocha, Vanderson; Ruggeri, Annalisa; Spellman, Stephen; Wang, Tao; Sobecks, Ronald; Locatelli, Franco; Askar, Medhat; Michel, Gerard; Arcese, William; Iori, Anna Paola; Purtill, Duncan; Danby, Robert; Sanz, Guillermo F.; Gluckman, Eliane; Eapen, Mary.

In: Biology of Blood and Marrow Transplantation, Vol. 22, No. 7, 01.07.2016, p. 1284-1289.

Research output: Contribution to journalArticle

Rocha, V, Ruggeri, A, Spellman, S, Wang, T, Sobecks, R, Locatelli, F, Askar, M, Michel, G, Arcese, W, Iori, AP, Purtill, D, Danby, R, Sanz, GF, Gluckman, E & Eapen, M 2016, 'Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia', Biology of Blood and Marrow Transplantation, vol. 22, no. 7, pp. 1284-1289. https://doi.org/10.1016/j.bbmt.2016.04.007
Rocha, Vanderson ; Ruggeri, Annalisa ; Spellman, Stephen ; Wang, Tao ; Sobecks, Ronald ; Locatelli, Franco ; Askar, Medhat ; Michel, Gerard ; Arcese, William ; Iori, Anna Paola ; Purtill, Duncan ; Danby, Robert ; Sanz, Guillermo F. ; Gluckman, Eliane ; Eapen, Mary. / Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. In: Biology of Blood and Marrow Transplantation. 2016 ; Vol. 22, No. 7. pp. 1284-1289.
@article{56d9401c02934351b25e714a0e4bb617,
title = "Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia",
abstract = "The effect of killer cell immunoglobulin-like receptor (KIR)-ligand matching on outcomes after unrelated cord blood (CB) transplantation was studied in 461 patients with acute myeloid leukemia, categorizing KIR ligand for HLA-C groups C1 and C2 and Bw4. Donor-recipient HLA matching considered allele-level matching at HLA-A, -B, -C, and -DRB1. Separate analyses were conducted for 6-7/8 HLA-matched and 3-5/8 HLA-matched transplants because HLA matching confounded KIR-ligand matching (ie, KIR-ligand mismatching was less likely with better HLA matching). All patients received single CB unit and myeloablative conditioning. There were no significant differences in nonrelapse mortality (NRM), relapse, and overall mortality by KIR-ligand match status. However, among recipients of 3-5/8 HLA-matched transplants, NRM (HR, 2.26; P = .008) and overall mortality (HR, 1.78; P = .008) but not relapse were higher with KIR-ligand mismatched (host-versus-graft direction) compared with KIR-ligand matched transplants. These data do not support selecting CB units based on KIR-ligand match status for transplants mismatched at 1 or 2 HLA loci. Although transplants mismatched at 3 or more HLA loci are not recommended, avoiding KIR-ligand mismatching in this setting lowers mortality risks.",
keywords = "Acute leukemia, Cord blood, KIR ligand, Unrelated transplant",
author = "Vanderson Rocha and Annalisa Ruggeri and Stephen Spellman and Tao Wang and Ronald Sobecks and Franco Locatelli and Medhat Askar and Gerard Michel and William Arcese and Iori, {Anna Paola} and Duncan Purtill and Robert Danby and Sanz, {Guillermo F.} and Eliane Gluckman and Mary Eapen",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.bbmt.2016.04.007",
language = "English",
volume = "22",
pages = "1284--1289",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia

AU - Rocha, Vanderson

AU - Ruggeri, Annalisa

AU - Spellman, Stephen

AU - Wang, Tao

AU - Sobecks, Ronald

AU - Locatelli, Franco

AU - Askar, Medhat

AU - Michel, Gerard

AU - Arcese, William

AU - Iori, Anna Paola

AU - Purtill, Duncan

AU - Danby, Robert

AU - Sanz, Guillermo F.

AU - Gluckman, Eliane

AU - Eapen, Mary

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The effect of killer cell immunoglobulin-like receptor (KIR)-ligand matching on outcomes after unrelated cord blood (CB) transplantation was studied in 461 patients with acute myeloid leukemia, categorizing KIR ligand for HLA-C groups C1 and C2 and Bw4. Donor-recipient HLA matching considered allele-level matching at HLA-A, -B, -C, and -DRB1. Separate analyses were conducted for 6-7/8 HLA-matched and 3-5/8 HLA-matched transplants because HLA matching confounded KIR-ligand matching (ie, KIR-ligand mismatching was less likely with better HLA matching). All patients received single CB unit and myeloablative conditioning. There were no significant differences in nonrelapse mortality (NRM), relapse, and overall mortality by KIR-ligand match status. However, among recipients of 3-5/8 HLA-matched transplants, NRM (HR, 2.26; P = .008) and overall mortality (HR, 1.78; P = .008) but not relapse were higher with KIR-ligand mismatched (host-versus-graft direction) compared with KIR-ligand matched transplants. These data do not support selecting CB units based on KIR-ligand match status for transplants mismatched at 1 or 2 HLA loci. Although transplants mismatched at 3 or more HLA loci are not recommended, avoiding KIR-ligand mismatching in this setting lowers mortality risks.

AB - The effect of killer cell immunoglobulin-like receptor (KIR)-ligand matching on outcomes after unrelated cord blood (CB) transplantation was studied in 461 patients with acute myeloid leukemia, categorizing KIR ligand for HLA-C groups C1 and C2 and Bw4. Donor-recipient HLA matching considered allele-level matching at HLA-A, -B, -C, and -DRB1. Separate analyses were conducted for 6-7/8 HLA-matched and 3-5/8 HLA-matched transplants because HLA matching confounded KIR-ligand matching (ie, KIR-ligand mismatching was less likely with better HLA matching). All patients received single CB unit and myeloablative conditioning. There were no significant differences in nonrelapse mortality (NRM), relapse, and overall mortality by KIR-ligand match status. However, among recipients of 3-5/8 HLA-matched transplants, NRM (HR, 2.26; P = .008) and overall mortality (HR, 1.78; P = .008) but not relapse were higher with KIR-ligand mismatched (host-versus-graft direction) compared with KIR-ligand matched transplants. These data do not support selecting CB units based on KIR-ligand match status for transplants mismatched at 1 or 2 HLA loci. Although transplants mismatched at 3 or more HLA loci are not recommended, avoiding KIR-ligand mismatching in this setting lowers mortality risks.

KW - Acute leukemia

KW - Cord blood

KW - KIR ligand

KW - Unrelated transplant

UR - http://www.scopus.com/inward/record.url?scp=84975275493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975275493&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.04.007

DO - 10.1016/j.bbmt.2016.04.007

M3 - Article

VL - 22

SP - 1284

EP - 1289

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 7

ER -